Overview

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effects of AZD6280 compared to lorazepam on sleepiness, concentration and brain activity.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Lorazepam